moxifloxacin has been researched along with tetradecanoylphorbol acetate in 3 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 31,050 | 61 | 2,217 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blau, H; Fabian, I; Halperin, D; Levitov, A; Shalit, I; Weiss, T; Werber, S | 1 |
Galley, HF; Watt, AM; Webster, NR; Williams, AC | 1 |
Hand, DL; Hand, WL; Vasquez, Y | 1 |
3 other study(ies) available for moxifloxacin and tetradecanoylphorbol acetate
Article | Year |
---|---|
Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Aza Compounds; Blotting, Western; Cytokines; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Fluoroquinolones; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monocytes; Moxifloxacin; NF-kappa B; Quinolines; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2004 |
Differential effects of three antibiotics on T helper cell cytokine expression.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Cells, Cultured; Ciprofloxacin; Clarithromycin; Cytokines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Interferon-gamma; Interleukin-4; Ionomycin; Lymphocyte Activation; Male; Middle Aged; Moxifloxacin; Quinolines; T-Lymphocytes, Helper-Inducer; Tetradecanoylphorbol Acetate; Th1 Cells; Th2 Cells | 2005 |
Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluoroquinolones; Humans; Male; Mexican Americans; Moxifloxacin; Neutrophils; Ofloxacin; Protein Kinase C; Quinolines; Respiratory Burst; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 2007 |